SEARCH

SEARCH BY CITATION

References

  • 1
    Fields LE, Burt VL, Cutler JA, et al. The burden of adult hypertension in the United States 1999 to 2000: a rising tide. Hypertension. 2004;44:398404.
  • 2
    Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:12061252.
  • 3
    Monane M, Glynn RJ, Gurwitz JH, et al. Trends in medication choices for hypertension in the elderly. The decline of the thiazides. Hypertension. 1995;25:10451051.
  • 4
    Siegel D, Lopez J. Trends in antihypertensive drug use in the United States: do the JNC V recommendations affect prescribing? Fifth Joint National Commission on the Detection, Evaluation, and Treatment of High Blood Pressure. JAMA. 1997;278:17451748.
  • 5
    Siegel D, Lopez J, Meier J, et al. Changes in the pharmacologic treatment of hypertension in the Department of Veterans Affairs 1997–1999: decreased use of calcium antagonists and increased use of beta-blockers and thiazide diuretics. Am J Hypertens. 2001;14:957962.
  • 6
    Xu KT, Moloney M, Phillips S. Economics of suboptimal drug use: cost-savings of using JNC-recommended medications for management of uncomplicated essential hypertension. Am J Manag Care. 2003;9:529536.
  • 7
    Henderson SO, Bretsky P, DeQuattro V, et al. Treatment of hypertension in African Americans and Latinos: the effect of JNC VI on urban prescribing practices. J Clin Hypertens (Greenwich). 2003;5:107112.
  • 8
    Cuspidi C, Michev I, Lonati L, et al. Compliance to hypertension guidelines in clinical practice: a multicentre pilot study in Italy. J Hum Hypertens. 2002;16:699703.
  • 9
    Asch SM, Kerr EA, Lapuerta P, et al. A new approach for measuring quality of care for women with hypertension. Arch Intern Med. 2001;161:13291335.
  • 10
    Hyman DJ, Pavlik VN. Self-reported hypertension treatment practices among primary care physicians: blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine. Arch Intern Med. 2000;160:22812286.
  • 11
    Mehta SS, Wilcox CS, Schulman KA. Treatment of hypertension in patients with comorbidities: results from the study of hypertensive prescribing practices (SHyPP). Am J Hypertens. 1999;12:333340.
  • 12
    Nelson CR, Knapp DA. Trends in antihypertensive drug therapy of ambulatory patients by US office-based physicians. Hypertension. 2000;36:600603.
  • 13
    Cloher TP, Whelton PK. Physician approach to the recognition and initial management of hypertension. Results of a statewide survey of Maryland physicians. Arch Intern Med. 1986;146:529533.
  • 14
    Manolio TA, Cutler JA, Furberg CD, et al. Trends in pharmacologic management of hypertension in the United States. Arch Intern Med. 1995;155:829837.
  • 15
    Naiman DJ, Barker LR. Adherence to the JNC VI guidelines for the treatment of hypertension in the resident clinic. Md Med J. 1999;48:307311.
  • 16
    Campbell NR, Tu K, Brant R, et al. The impact of the Canadian Hypertension Education Program on antihypertensive prescribing trends. Hypertension. 2006;47:2228.
  • 17
    Milchak JL, Carter BL, James PA, et al. Measuring adherence to practice guidelines for the management of hypertension: an evaluation of the literature. Hypertension. 2004;44:602608.
  • 18
    Milchak JL, Carter BL, Ardery G, et al. Development of explicit criteria to measure adherence to hypertension guidelines. J Hum Hypertens. 2006;20:426433.
  • 19
    Okonofua EC, Simpson KN, Jesri A, et al. Therapeutic inertia is a impediment to achieving the Healthy People 2010 blood pressure control goals. Hypertension. 2006;47:345351.
  • 20
    Berlowitz DR, Ash AS, Hickey EC, et al. Inadequate management of blood pressure in a hypertensive population. N Engl J Med. 1998;339:19571963.
  • 21
    Oliveria SA, Lapuerta P, McCarthy BD, et al. Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med. 2002;162:413420.
  • 22
    Andrade SE, Gurwitz JH, Field TS, et al. Hypertension management: the care gap between clinical guidelines and clinical practice. Am J Manag Care. 2004;10:481486.
  • 23
    Minami J, Ishimitsu T, Matsuoka H. Effects of smoking cessation on blood pressure and heart rate variability in habitual smokers. Hypertension. 1999;33:586590.
  • 24
    Baster T, Baster-Brooks C. Exercise and hypertension. Aust Fam Physician. 2005;34:419424.
  • 25
    Sacks FM, Svetkey LP, Vollmer WM, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) Diet. N Engl J Med. 2001;344:310.
  • 26
    Bentsen BG. The accuracy of recording patient problems in family practice. J Med Educ. 1976;51:311316.
  • 27
    Romm FJ, Putnam SM. The validity of the medical record. Med Care. 1981;19:310315.
  • 28
    Tufo HM, Speidel JJ. Problems with medical records. Med Care. 1971;9:509517.
  • 29
    Zuckerman ZE, Starfield B, Hochreiter C, et al. Validating the content of pediatric outpatient medical records by means of tape-recording doctor-patient encounters. Pediatrics. 1975;56:407411.
  • 30
    Lyons TF, Payne BC. The relationship of physicians' medical recording performance to their medical care performance. Med Care. 1974;12:714720.